Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acquired sulfhemoglobinemia. An underreported diagnosis?

Literature DB >> 9866446

Acquired sulfhemoglobinemia. An underreported diagnosis?

M Noor¹, E Beutler.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1998 PMID： 9866446 PMCID： PMC1305417

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

× No keyword cloud information.

7 in total

1. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia.

Authors: N GOLUBOFF; R WHEATON
Journal: J Pediatr Date: 1961-01 Impact factor: 4.406

2. Sulphemo-globinemia following habitual use of acetanild.

Authors: T B REYNOLDS; A G WARE
Journal: J Am Med Assoc Date: 1952-08-23

3. Sulfhaemoglobin. Absorption spectrum, millimolar extinction coefficient at lambda = 620 nm, and interference with the determination of haemoglobin and of haemiglobincy anide.

Authors: P Dijkhuizen; A Buursma; A M Gerding; W G Zijlstra
Journal: Clin Chim Acta Date: 1977-08-01 Impact factor: 3.786

4. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

Authors: P J Rosen; C Johnson; W G McGehee; E Beutler
Journal: Ann Intern Med Date: 1971-07 Impact factor: 25.391

5. Sulfhemoglobinemia. Clinical and molecular aspects.

Authors: C M Park; R L Nagel
Journal: N Engl J Med Date: 1984-06-14 Impact factor: 91.245

6. A multi-wavelength spectrophotometric method for the simultaneous determination of five haemoglobin derivatives.

Authors: A Zwart; A Buursma; E J van Kampen; B Oeseburg; P H van der Ploeg; W G Zijlstra
Journal: J Clin Chem Clin Biochem Date: 1981-07

7. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia.

Authors: J W Harvey; A S Keitt
Journal: Br J Haematol Date: 1983-05 Impact factor: 6.998

7 in total

9 in total

1. Case files of the University of Cincinnati fellowship in medical toxicology: two patients with acute lethal occupational exposure to hydrogen sulfide.

Authors: Michael A Policastro; Edward J Otten
Journal: J Med Toxicol Date: 2007-06

2. Sulfhaemoglobinaemia caused by ferrous sulfate.

Authors: Laith Derbas; Mohamed Warsame; Mohannad Abu Omar; Yousaf Zafar; Gregory Howell
Journal: BMJ Case Rep Date: 2017-06-13

3. [Blood gas analysis error].

Authors: Anna Steinacher; Georg-Christian Funk; Stefan Pöchacker; Lukas-Maurice Scheinost; Philip Eisenburger
Journal: Med Klin Intensivmed Notfmed Date: 2021-08-10 Impact factor: 0.840

Review 4. Hydrogen sulfide activation in hemeproteins: the sulfheme scenario.

Authors: Bessie B Ríos-González; Elddie M Román-Morales; Ruth Pietri; Juan López-Garriga
Journal: J Inorg Biochem Date: 2014-01-25 Impact factor: 4.155

Review 5. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H₂S Levels: H₂S Donors and H₂S Biosynthesis Inhibitors.

Authors: Csaba Szabo; Andreas Papapetropoulos
Journal: Pharmacol Rev Date: 2017-10 Impact factor: 25.468

Acquired sulfhemoglobinemia. An underreported diagnosis?

1. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia.

2. Sulphemo-globinemia following habitual use of acetanild.

3. Sulfhaemoglobin. Absorption spectrum, millimolar extinction coefficient at lambda = 620 nm, and interference with the determination of haemoglobin and of haemiglobincy anide.

4. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

5. Sulfhemoglobinemia. Clinical and molecular aspects.

6. A multi-wavelength spectrophotometric method for the simultaneous determination of five haemoglobin derivatives.

7. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia.

1. Case files of the University of Cincinnati fellowship in medical toxicology: two patients with acute lethal occupational exposure to hydrogen sulfide.

2. Sulfhaemoglobinaemia caused by ferrous sulfate.

3. [Blood gas analysis error].

Review 4. Hydrogen sulfide activation in hemeproteins: the sulfheme scenario.

Review 5. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H₂S Levels: H₂S Donors and H₂S Biosynthesis Inhibitors.

6. Sulfmyoglobin Conformational Change: A Role in the Decrease of Oxy-Myoglobin Functionality.

7. A case of sulfhemoglobinemia in a child with chronic constipation.

8. Methemoglobinemia and sulfhemoglobinemia in two pediatric patients after ingestion of hydroxylamine sulfate.

9. Methylene blue unresponsive methemoglobinemia.

Review 4. Hydrogen sulfide activation in hemeproteins: the sulfheme scenario.

Review 5. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Review 5. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H₂S Levels: H₂S Donors and H₂S Biosynthesis Inhibitors.